Safety of tacrolimus monotherapy within 12 months after liver transplantation in the era of reduced tacrolimus and mycophenolate mofetil: national registry study

HIGHLIGHTS

• who: Deok Gie Kim and colleagues from the Department of Biostatistics, Yonsei University Wonju College of Medicine, Wonju , have published the research work: Safety of Tacrolimus Monotherapy within 12 Months after Liver Transplantation in the Era of Reduced Tacrolimus and Mycophenolate Mofetil: National Registry Study, in the Journal: (JOURNAL)
• what: The authors reduced such biases by a systematic matching process using time-conditional propensity scores, allowing the authors to reasonably compare outcomes in TAC-mono and TAC/MMF groups that included patients with similar underlying conditions and time-varying factors, such as liver function, renal . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.